Related Experiment Videos
[Carcinoid of the rectum].
Voprosy Onkologii
|January 1, 1990
Summary
Rectal carcinoid tumors are very rare, accounting for only 0.4% of rectal cancers. Due to unclear malignancy criteria, surgical removal is the only effective treatment for these rare neuroendocrine neoplasms.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Pathology
Context:
- Rectal carcinoid tumors represent an exceptionally rare subset of rectal malignancies, comprising approximately 0.4% of all cases.
- The diagnostic criteria for determining the malignant potential of these neuroendocrine tumors remain incompletely defined.
- Current understanding suggests limited therapeutic options beyond surgical intervention.
Purpose:
- To highlight the rarity and diagnostic challenges associated with rectal carcinoid tumors.
- To emphasize the current limitations in defining malignancy criteria for these neoplasms.
- To underscore the established role of surgery as the primary radical treatment modality.
Summary:
- Rectal carcinoid tumors are exceedingly uncommon, constituting a small fraction of all rectal cancers.
- Morphological features predictive of malignancy in these tumors are not well-established.
- Surgical resection is identified as the sole definitive curative treatment approach.
Impact:
- This information is crucial for clinicians managing rare rectal neoplasms.
- Highlights the need for further research into the biological behavior and diagnostic markers of rectal carcinoids.
- Reinforces the importance of surgical expertise in the management of these rare tumors.